최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한방비만학회지 = Journal of Korean Medicine for Obesity Research, v.17 no.2, 2017년, pp.68 - 76
강은영 (경희대학교 대학원 한방인체정보의학과) , 박영배 (경희대학교 대학원 한방인체정보의학과) , 김민용 (경희대학교 대학원 한방인체정보의학과) , 박영재 (경희대학교 대학원 한방인체정보의학과)
Objectives: The purpose of this study was to analyze the factors affecting weight loss effect of Gamitaeumjowee-tang and to see if weight loss could be predicted using influence factors and weight loss progress. Methods: From September 2016 to March 2017, we retrospectively reviewed the medical reco...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
비만이란? | 비만은 체내 체지방의 과도한 축적을 말하며, 섭취에너지가 소비에너지를 초과하는 에너지 불균형이 오랜 기간 유발됨으로써 발생한다1). 연령, 인종, 가족력 등의 유전적 요인 못지 않게 서구화로 인한 식단변화, 활동량의 감소 등 환경적 요인도 비만 유발에 크게 관여하는 것으로 밝혀져 있다1). | |
비만의 발생원인은? | 비만은 체내 체지방의 과도한 축적을 말하며, 섭취에너지가 소비에너지를 초과하는 에너지 불균형이 오랜 기간 유발됨으로써 발생한다1). 연령, 인종, 가족력 등의 유전적 요인 못지 않게 서구화로 인한 식단변화, 활동량의 감소 등 환경적 요인도 비만 유발에 크게 관여하는 것으로 밝혀져 있다1). | |
한의학적 비만치료중 약물치료에는 어떤것들이 있는가? | 한의학적 비만치료는 한약을 이용한 약물치료, 침구치료, 원적외선요법 등 다양하게 이뤄지고 있다3) . 약물치료에서는 태음조위탕, 방풍통성산, 체감의이인탕 등의 복합처방이 많이 사용되고 있고4) , 그 중 태음조위탕은 태음인의 胃脘受寒表寒病에 쓰이는 사상처방5)으로 비만 치료에서 유효성이 입증되면서 원방 및 그 가미방이 임상에서 다용되고 있다6-9). 그러나 이제까지의 한의학적 비만치료 관련 연구는 우수한 체중감량 효과 여부를 입증하는 데 집중한 반면, 비만치료와 관련하여 약물효과의 장기간 추적관찰이나10), 약물치료와 수술치료의 비교연구11) 등의 다양한 연구 수행이 부족한 실정이다. |
Haidar YM, Cosman BC. Obesity epidemiology. Clin Colon Rectal Surg. 2011 ; 24(4) : 205-10.
Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2014: Korea National Health and Nutrition Examination Survey (KNHANES VI-2). Sejong, Cheongju : Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. 2014.
Hwang MJ, Shin HD, Song MY. Literature review of herbal medicines on treatment of obesity since 2000-mainly about Ephedra Herba. J Soc Korean Med Obes Res. 2007 ; 7(1) : 39-54.
Lee JM. Longevity and life preservation in Eastern medicine, Seoul : Haklimsa. 1986 : 333-8.
Lim SY, Park SW, Joo JH, Kim SR, Kim DJ, Choi WS. The effects of Taeeumjowui-tang (Taiyintiaowei-tang) on obesity in Sasang constitution. J East-West Med. 2012 ; 37(4) : 109-16.
Park KM, Song YK, Lim HH. Review on the research relative to taeeumjowui-Tang (Taiyintiaowei-tang). J Soc Korean Med Obes Res. 2009 ; 9(1) : 23-6.
Lee JE, Song YK, Lim HH. Clinical trial of Taeeumjowui-tang (Taiyintiaowei-tang) on obese patients: randomized, double blind, placebo-controlled study. J Orient Rehab Med. 2010 ; 20(4) : 197-213.
Park SJ, Nahmkoong W, Cheon CH, Park JS, Jang BH, Shin YC, et al. Efficacy and safety of Taeeumjowi-tang in obese Korean adults: a double-blind, randomized, and placebo-controlled pilot trial. Evid-Based Complement Altern Med. 2013 ; 2013 : 498935.
Hansen D, Astrup A, Toubro S, Finer N, Kopelman P, Hilsted J, et al. Predictors of weight loss and maintenance during 2 years of treatment by sibutramine in obesity-results from the European multi-centre STORM trial. Int J Obes Relat Metab Disord. 2001 ; 25(4) : 496-501.
Heo YS, Park JM, Kim YJ, Kim SM, Park DJ, Lee SK, et al. Bariatric surgery versus conventional therapy in obese Korea patients: a multicenter retrospective cohort study. J Korean Surg Soc. 2012 ; 83(6) : 335-42.
Fabricatroe AN. Predictors of attrition and weight loss success: results from a randomized controlled trial. Behav Res Ther. 2009 ; 47(8) : 685-91.
Wright SM, Aronne LJ. Causes of obesity. Abdom Imaging. 2012 ; 37(5) : 730-2.
Kim SY, Park YJ, Park YB. Review on predictors of dropout and weight loss maintenance in weight loss interventions. J Korean Med. 2016 ; 39(3) : 62-73.
Dhurandhar NA, Blank RC, Schumacher D, Atkinson RL. Initial weight loss as a predictor of response to obesity drugs. Int J Obes Relat Metab Disord. 1999 ; 23(12) : 1333-6.
Handjieva-Darlenska T, Handjiev S, Larsen TM, van Baak MA, Jebb S, Papadaki A, et al. Initial weight loss on an 800-kcal diet as a predictor of weight loss success after 8 weeks: the Diogenes study. Eur J Clin Nutr. 2010 ; 64(9) : 994-9.
Park HS, Kim KS, Kim BT, Lee KW, Ahn CW, Choi WH. Double-blind, randomized, multi-center, comparative clinical trial of Sibutramine Mesilate with Sibutramine hydrochloride for evaluating efficacy and safety in obese patients. Korean J Obes. 2008 ; 17(2) : 82-90.
Park CY, Kim YS, Ryu MS, Nam SY, Park HS, Kim SM. A phase 3 double-blind, parallel-group, placebo-controlled trail of the efficacy and safety of sibutramine (Reductil) in the treatment of obese patients. Korean J Obes. 2001 ; 10(4) : 336-47.
Spitzer RL, Kroenke K, Williams JBW. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999 ; 282(18) : 1737-44.
Lim KH, Park YN, Kim DH, Shin IH, Lee WS, Kim JB. A preliminary study of the standardization of the Korean version of Patient Health Questionnaire-9. Korean J Helath Promot Dis Prev. 2009 ; 9(4) : 275-81.
Department of Biofunctional Medicine&Dianostics in Colleges of Korean Medicine. Biofunctional medicine. Paju : Koonja. 2008 : 81-101.
Sartorio A, Maffiuletti NA, Agosti F, Lafortuna CL, Genderrelated changes in body composition, muscle strength and power output after a short-term multidisciplinary weight loss intervention in morbid obesity. J Endocrinol Invest. 2005 ; 28(6) : 494-501.
Goode RW, Ye L, Sereika SM, Zheng Y, Mattos M, Acharya SD, et al. Socio-demographic, anthropometric and psychosocial predictors of attrition across behavioral weight loss trials. Sour Doc Eat Behav. 2016 ; 20 : 27-33.
Jung HH, Choi YS, Kim SH, Sohn KJ, Kim DG, Hong JI, et al. Association between metabolic syndrome and heart rate variability. Korean J Obes. 2005 ; 14(4) : 220-7.
Moroshko I, Brennan L, O'Brien P. Predictor of dropout in weight loss interventions a systematic review of the literature. Obes Rev. 2011 ; 12(11) : 912-34.
Coughlin JW, Smith MT. Sleep, obesity, and weight loss in adults: is there a rationale for providing sleep interventions in the treatment of obesity? Int Rev Psychiatry. 2014 ; 26(2) : 177-88.
Kase CA, Piers AD, Schuamberg K, Forman EM, Butryn ML. The relationship of alcohol use to weight loss in the context of behavioral weight loss treatment. Appetite. 2016 ; 99 : 105-11.
Alizai PH, Akkerman MK, Kaemmer D, Ulmer F, Klink CD, Ernst S, et al. Presurgical assessment of bariatric patients with the Patient Health Questionnaire (PHQ)-A screening of the prevalence of psychosocial comorbidity. Health Qual Life Outcome. 2015 ; 13(1) : 80-6.
Ludman E, Simon G, Ichikawa L, Operskalski B, Arteburn D, Linde J, et al. Does depression reduce the effectiveness of behavioral weight loss treatment? Behav Med. 2009 ; 35(4) : 126-34.
Latner JD, Ciao AC. Weight-loss history as a predictor of obesity treatment outcome: prospective, long-term results from behavioral, group self-help treatment. J Health Psychology. 2014 ; 19(2) : 253-61.
Yackobovitch-Gavan M, Steinberg DM, Endevelt R, Benyamini Y. Factors associated with dropout in a group weight-loss programme: a longitudinal investigation. J Hum Nutr Diet. 2015 ; 28(2) : 33-40.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.